![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Repeat dosing of the GalNAc-siRNA AB-729 in subjects
with chronic hepatitis B results in robust
and sustained HBsAg suppression
|
|
|
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
MF Yuen1, E Berliba2, W Sukeepaisarnjaroen3, S Strasser4, P Tangkijvanich5, J Holmes6, A Leerapun7, A Jucov2, EP Thi8,
P Wattamwar8, M Sofia8, H Sevinsky8, K Gray8, D Antoniello8, T Eley8, G Picchio8, KD Sims8, E Gane9
![0627211](../images/062721/062721-4/0627211.gif)
![0627212](../images/062721/062721-4/0627212.gif)
![0627213](../images/062721/062721-4/0627213.gif)
![0627214](../images/062721/062721-4/0627214.gif)
![0627215](../images/062721/062721-4/0627215.gif)
![0627216](../images/062721/062721-4/0627216.gif)
![0627217](../images/062721/062721-4/0627217.gif)
![0627218](../images/062721/062721-4/0627218.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|